Exercised-induced vasovagal syncope: Limiting the risks

Physician and Sportsmedicine

Volumn 25, Issue 5, 1997, Pages 64-74

  Wang, David ^a   Sakaguchi, Scott ^c   Babcock, Marcella ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Two Rivers Center Inc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE PHOSPHATE; FLUDROCORTISONE ACETATE; FLUOXETINE; MIDODRINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ATHLETE; CASE REPORT; DEHYDRATION; DIAGNOSTIC PROCEDURE; EXERCISE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SYNCOPE; TILTING;

EID: 0030917057     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.1997.05.1345     Document Type: Review

References (27)

1. Hart GT: Evaluation of syncope. Am Fam Physician 1995;51(8):1941-1948, 1951-1952
2. Savage DD, Corwin L, McGee DL, et al: Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16(4):626-629
3. Gendelman HE, Linzer M, Gabelman, et al: Syncope in a general hospital patient population. NY State J Med 1983;83:1161-1165
4. Benditt DG, Sakaguchi S, Shultz JJ, et al: Syncope: diagnostic considerations and role of tilt table testing. Cardiol Rev 1993;1(3):146-156
5. Chen MY, Goldenberg IF, Milstein S, et al: Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol 1989;63 (1):66-72
6. Kosinski D, Grubb BP Kip K, et al: Exercise-induced neurogenic syncope. Am Heart J 1996;132(2 pt 1): 451-452
7. Chosy JJ, Graham DT: Catecholamines in vasovagal fainting. J Psychosom Res 1965;9(2):189-194
8. Fitzpatick A, Williams T, Ahmed R, et al: Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. European Journal of Cardiac Pacing and Electrophysiology 1992;2:121-128
9. Sakaguchi S, Shultz JJ, Remote SC, et al: Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol 1995;75(7):476-481
10. Scherrer U, Vissing S, Morgan BJ, et al: Vasovagal syncope after infusion of a vasodilator in a heart transplant recipient. N Engl J Med 1990;332(9): 602-604
11. Wallin BG, Sundlof G: Sympathetic outflow in muscles during vasovagal syncope. J Auton Nerv Syst 1982;6(3):287-291
12. Grubb BP, Gerard G, Roush K, et al: Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope: a paradoxic and unexpected response. Circulation 1991;84(3):1157-1164
13. Grubb BP, Temesy-Armos PN, Samoil D, et al: Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope. Med Sci Sports Exerc 1993;25(1):24-28
14. Morillo CA, Klein GJ, Zandri S, et al: Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995;129(5):901-906
15. Stegemann J: Relation between training status and orthostatic tolerance. Cardiology 1976;61(suppl 1): 255-266
16. Raven PB, Pawelczyk JA: Chronic endurance exercise training: a condition of inadequate blood pressure regulation and reduced tolerance to LBNP. Med Sci Sports Exerc 1993;25(6):713-721
17. Convertino VA: Endurance exercise training: conditions of enhanced hemodynamic responses and tolerance to LBNP. Med Sci Sports Exerc 1993;25(6): 705-712
18. Benditt DG, Ferguson DW, Grubb BP, et al: Tilt table testing for assessing syncope: American College of Cardiology. J Am Coll Cardiol 1996;28(1):263-275
19. Almquist A, Goldenberg IF, Milstein S, et al: Provocation of bradycardia and hypotension by isoproterenol in patients with unexplained syncope. N Engl J Med 1989;320(6):346-351
20. Milstein S, Buetikofer J, Dunnigan A, et al: Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990;65(20):1339-1344
21. Abboud FM: Neurocardiogenic syncope. N Engl J Med 1993;328(15):1085-1090
22. Grubb BP, Wolfe DA, Samoil D, et al: Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol 1993;16(3):458-464
23. Low PA, Gilden JL, Freeman R, et al: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA 1997;277(13):1046-1051
24. Newsholme EA, Acworth IN, Blomstrand E: Amino acids, brain transmitters and a functional link between muscle and brain that is important in sustained exercise, in Benzi G (ed): Advances in Myochemistry. London, John Libbey Eurotext, 1987, pp 127-133
25. Davis JM, Bailey SP, Jackson DA, et al: Effects of a serotonin (5-HT) agonist during prolonged exercise to fatigue in humans, abstract. Med Sci Sports Exerc 1993;25(5):378
26. Wilson WM, Maughan RJ: Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 1992;77(6):921-924
27. Calkins H, Seifert M, Morady F: Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope. Am Heart J 1995;129(6):1159-1164